There is provided compounds of formula I, wherein ring R
1a
to R
1c
, R
2a
to R
2e
, and X have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C
4
synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.